Memory and mood-enhancing neuroprotective effects of visible light photoactivated gold nanoparticles and PEG3350 coating in a rat animal model
Source abstract
Abstract
Gold nanoparticles (AuNPs) emerge as promising neuromodulatory biomaterials due to their tunable optical properties, biocompatibility, and ability to cross the blood-brain barrier. Here, we investigated the behavioral and neuroprotective effects of citrate-stabilized AuNPs (~ 19 nm) coated with PEG3350 and irradiated under white (AuWL+PEG) or green light (AuGL+PEG), compared with non-irradiated PEGylated AuNPs (AuNP+PEG). Comprehensive physicochemical analyses demonstrated that green-light irradiation enhanced surface plasmon resonance (SPR) activity, improved PEG adsorption, and yielded superior colloidal stability relative to white-light irradiation. In vivo evaluation in Wistar rats revealed that AuGL+PEG produced robust anxiolytic-like effects in the elevated plus maze, significantly enhanced spatial working memory in the Y-maze, and improved performance in the radial arm maze, approaching the efficacy of donepezil. In the forced swimming test, AuGL+PEG also produced the most favorable antidepressant-like profile, reducing immobility without locomotor confounds. Biochemically, AuGL+PEG markedly enhanced antioxidant capacity, increasing SOD, CAT, GPX, and GSH levels while reducing lipid peroxidation (MDA), consistent with restored redox homeostasis. Acetylcholinesterase inhibition was significantly greater in irradiated groups, supporting improved cholinergic signaling. Toxicological evaluation indicated no major systemic or hematological toxicity at the administered doses. Collectively, the findings demonstrate that light-engineered PEGylated AuNPs, particularly those activated with green light, exhibit potent neuroprotective and cognition-enhancing effects mediated by plasmonic surface optimization, antioxidant defense reinforcement, and cholinergic modulation. These results identify AuGL+PEG as a promising candidate nanomaterial for future applications in neuromodulation, cognitive enhancement, and the treatment of neurodegenerative diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Laser Applications in Dentistry and Medicine · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview10.1021/la0513712 ↗
2. Nanoparticles and microparticles for drug and vaccine delivery
3. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting10.1146/annurev.bioeng.8.061505.095735 ↗
4. Nanoparticle dermal absorption and toxicity: a review of the literature10.1007/s00420-009-0458-x ↗
5. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities10.1016/j.pharmthera.2004.08.001 ↗
6. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound10.1016/j.nano.2012.02.003 ↗
7. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice10.1016/j.biomaterials.2008.12.038 ↗
8. Controlled PEGylation of monodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cells10.1002/adma.200701975 ↗
9. Two-step functionalization of neutral and positively charged thiols onto citrate-stabilized au nanoparticles10.1021/jp036310w ↗
10. Targeting of nanoparticles to the clathrin-mediated endocytic pathway10.1016/j.bbrc.2006.11.135 ↗
11. Uptake and intracellular fate of surface-modified gold nanoparticles10.1021/nn800330a ↗
12. Gold and silver nanoparticles in Alzheimer’s and Parkinson’s diagnostics and treatments10.1002/ibra.12126 ↗
13. Gold nanoparticles in neurological diseases: a review of neuroprotection10.3390/ijms25042360 ↗
14. Green-synthesized gold nanoparticles exhibit neuroprotective activity against oxidative stress-induced damage in SH-SY5Y cells10.1007/s11051-025-06387-y ↗
15. Systemic administration of gold nanoparticles attenuates anxiety-related behaviors and enhances spatial learning performance in rats10.1016/j.ibneur.2025.08.004 ↗
16. Neuroprotective effect of gold nanoparticles and alpha-lipoic acid mixture against radiation-induced brain damage in rats10.3390/ijms23179640 ↗
17. Gold nanoparticles (AuNPs)—toxicity, safety and green synthesis: a critical review10.3390/ijms25074057 ↗
18. In vivo bio-distribution and acute toxicity evaluation of greenly synthesized ultra-small gold nanoparticles with different biological activities10.1038/s41598-022-10251-7 ↗
19. Long-term accumulation, biological effects and toxicity of BSA-coated gold nanoparticles in the mouse liver, spleen, and kidneys10.2147/IJN.S443168 ↗
20. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice10.1016/j.bbrc.2010.02.046 ↗
21. Anxiolytic and antidepressant-like effects of Conyza canadensis aqueous extract in the scopolamine rat model10.3390/plants10040645 ↗
22. Ambroxol rescues cognitive impairment by ameliorating oxidative stress and autophagic dysfunction in the streptozotocin-induced Alzheimer’s disease model10.1016/j.ejphar.2025.178334 ↗
23. Tetraclinis articulata essential oil mitigates cognitive deficits and brain oxidative stress in an Alzheimer’s disease amyloidosis model10.1016/j.phymed.2018.10.032 ↗
24. Measurement of protein using bicinchoninic acid10.1016/0003-2697(85)90442-7 ↗
25. The estimation of red cell superoxide dismutase activity
26. Colorimetric assay of catalase10.1016/0003-2697(72)90132-7 ↗
27. Glutathione peroxidase activity in tissues of vitamin E-deficient mice10.3177/jnsv.22.405 ↗
28. Protein carbonylation: avoiding pitfalls in the 2,4-dinitrophenylhydrazine assay10.1179/135100009X392601 ↗
29. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction10.1016/0003-2697(79)90738-3 ↗
30. UV-assay with pyruvate and NADH10.1016/B978-0-12-091302-2.50010-4 ↗
31. A new and rapid colorimetric determination of acetylcholinesterase activity10.1016/0006-2952(61)90145-9 ↗
32. Optical properties and ultrafast dynamics of metallic nanocrystals10.1146/annurev.physchem.54.011002.103759 ↗
33. The golden age: gold nanoparticles for biomedicine10.1039/C1CS15237H ↗
34. The effect of visible light on gold nanoparticles and some bioeffects on environmental fungi10.1016/j.ijpharm.2016.04.004 ↗
35. What’s so hot about electrons in metal nanoparticles?10.1021/acsenergylett.7b00333 ↗
36. Theory of photoinjection of hot plasmonic carriers from metal nanostructures into semiconductors and surface molecules10.1021/jp405430m ↗
37. Photochemical transformations on plasmonic metal nanoparticles10.1038/nmat4281 ↗
38. Nanoparticle-mediated cellular response is size-dependent10.1038/nnano.2008.30 ↗
39. Interaction of colloidal nanoparticles with their local environment: the (ionic) nanoenvironment around nanoparticles is different from bulk and determines the physico-chemical properties of the nanoparticles10.1098/rsif.2013.0931 ↗
40. Kinetic assembly of near-IR-active gold nanoclusters using weakly adsorbing polymers to control the size10.1021/la904793t ↗
41. Production and characterization of a budesonide nanosuspension for pulmonary administration10.1023/A:1014276917363 ↗
42. Silver nanoparticles in complex biological media: assessment of colloidal stability and protein corona formation10.1007/s11051-016-3560-5 ↗
43. Quantification of the PEGylated Gold nanoparticles protein corona. Influence on nanoparticle size and surface chemistry10.3390/app9224789 ↗
44. Boosting cancer cell uptake of gold nanoparticles by light-modulated protein Corona reorganization for tumor ablation10.1021/acsnano.5c01696 ↗
45. Photochemical transformations of thiolated polyethylene glycol coatings on gold nanoparticles10.1039/C6EN00141F ↗
46. Facile synthesis of PEGylated gold nanoparticles for enhanced colorimetric detection of histamine10.1021/acsomega.3c10050 ↗
47. Selection of cryoprotectants for freezing and freeze-drying of gold nanoparticles towards further uses in various applications10.1016/j.colsurfb.2022.112702 ↗
48. Hydrodynamic diameter and zeta potential of nanostructured lipid carriers: emphasizing some parameters for correct measurements10.1016/j.colsurfa.2021.126610 ↗
49. Fabrication and catalytic activity of thermally stable Gold nanoparticles on Ultrastable Y (USY) zeolites10.3390/catal3030599 ↗
50. pH-dependent aggregation of citrate-capped Au nanoparticles induced by Cu2+ ions: the competition effect of hydroxyl groups with the carboxyl groups10.1016/j.colsurfa.2009.06.023 ↗
51. Characterization of the surface of a citrate-reduced colloid optimized for use as a substrate for surface-enhanced resonance Raman scattering10.1021/la00010a021 ↗
52. Oxidation of formic acid and carbon monoxide on gold electrodes studied by surface-enhanced Raman spectroscopy and DFT10.1002/cphc.200500198 ↗
53. Mechanism of gold metal ion reduction, nanoparticle growth and size control in aqueous amphiphilic block copolymer solutions at ambient conditions10.1021/jp046221z ↗
54. Structural study of citrate layers on gold nanoparticles: role of intermolecular interactions in stabilizing nanoparticles10.1021/ja4097384 ↗
55. Conformational study of citrates adsorbed on gold nanoparticles using Fourier transform infrared spectroscopy10.1142/S0218863508004032 ↗
56. The effect of different molecular weight of poly(ethylene glycol) on the electrokinetic and rheological properties of Na-bentonite suspensions10.1016/j.colsurfa.2007.09.039 ↗
57. Nicotinamide pelletization by fluidized hot melt granulation: L18 Hunter design to screen high risk variables10.1016/j.ijpharm.2014.03.008 ↗
58. PEGylated gold nanoparticles target age-associated B cells in vivo10.1021/acsnano.2c04871 ↗
59. Gold nanoparticles (AuNPs)-toxicity, safety and green synthesis: a critical review10.3390/ijms25074057 ↗
60. Gold nanoparticles in neurological diseases: a review of neuroprotection10.3390/ijms25042360 ↗
61. Toxicological comparison between gold nanoparticles in different shapes: nanospheres exhibit less hepatotoxicity and lipid dysfunction and nanotriangles show lower neurotoxicity10.1021/acsomega.4c05961 ↗
62. Application of nanoparticles in the treatment of acute lung injury: current situation and future directions
63. The research of toxicity and sensitization potential of PEGylated silver and gold nanomaterials10.3390/toxics9120355 ↗
64. Immunomodulatory effects of gold nanoparticles: impacts on immune cells and mechanisms of action10.3390/nano15151201 ↗
65. Understanding the molecular toxicity of metal-based nanoparticles through nanotoxicomics10.2147/IJN.S553276 ↗
66. Immunomodulatory effects of gold nanoparticles: impacts on immune cells and mechanisms of action10.3390/nano15151201 ↗
67. Clinical laboratory parameters for Crl: Wi(Han) rats, (n.d.). https://hero.epa.gov/reference/1873773/ (accessed February 9, 2026).
68. Spectroscopic assessment of gold nanoparticle biodistribution using surface plasmon resonance phenomena10.1021/acsbiomaterials.9b01079 ↗
69. Engineered nanomaterials and type I allergic hypersensitivity reactions10.3389/fimmu.2020.00222 ↗
70. Nanoparticle-induced immune response: health risk versus treatment opportunity?10.1016/j.imbio.2022.152317 ↗
71. Recent advances in the protective role of metallic nanoparticles in red blood cells10.1007/s13205-021-03087-x ↗
72. From blood to therapy: the revolutionary application of platelets in cancer-targeted drug delivery10.3390/jfb16010015 ↗
73. Safety evaluation of PEGylated MNPs and p-PEGylated MNPs in SD rats10.1038/s41598-023-48742-w ↗
74. Systemic administration of gold nanoparticles attenuates anxiety-related behaviors and enhances spatial learning performance in rats10.1016/j.ibneur.2025.08.004 ↗
75. Impact of chronic oral administration of gold nanoparticles on cognitive abilities of mice10.3390/ijms24108962 ↗
76. S. Linic, U. Aslam, C. Boerigter, M. Morabito, Photochemical transformations on plasmonic metal nanoparticles, Nat. Mater. 2015 14:6 14 (2015) 567–576. doi:https://doi.org/10.1038/nmat4281.10.1038/nmat4281 ↗
77. Evidence and implications of direct charge excitation as the dominant mechanism in plasmon-mediated photocatalysis10.1038/ncomms10545 ↗
78. Plasmon-driven chemistry10.1146/annurev-physchem-082423-031814 ↗
79. Plasmonic metal nanostructures: concepts, challenges and opportunities in photo-mediated chemical transformations10.1016/j.isci.2020.101982 ↗
80. Green-synthesized gold nanoparticles exhibit neuroprotective activity against oxidative stress-induced damage in SH-SY5Y cells10.1007/s11051-025-06387-y ↗
81. Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer’s disease10.1039/D3TB01023F ↗
82. Nanoparticles: a hope for the treatment of inflammation in CNS
83. Metal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function10.1039/D4RA07798A ↗
84. Gold nanoparticles for modulating neuronal behavior10.3390/nano7040092 ↗
85. Effects of gold nanoparticles administration through behavioral and oxidative parameters in animal model of Parkinson’s disease10.1016/j.colsurfb.2020.111302 ↗
86. Plasmon-induced hot electrons in nanostructured materials: generation, collection, and application to photochemistry10.1021/acs.chemrev.4c00165 ↗
87. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery10.1016/j.addr.2015.09.012 ↗
88. Systemic administration of gold nanoparticles attenuates anxiety-related behaviors and enhances spatial learning performance in rats10.1016/j.ibneur.2025.08.004 ↗
89. Effects of gold nanoparticles administration through behavioral and oxidative parameters in animal model of Parkinson’s disease10.1016/j.colsurfb.2020.111302 ↗
90. Gold nanoparticles for modulating neuronal behavior10.3390/nano7040092 ↗
91. Gold nanoparticles and induction of structural alteration and enhanced oxidative stress in rat lens10.1016/j.fct.2025.115263 ↗
92. Understanding hot-electron generation and plasmon relaxation in metal nanocrystals: quantum and classical mechanisms10.1021/acsphotonics.7b00751 ↗
93. Ultrafast dynamics of nonthermal carriers following plasmonic and interband photoexcitation of 2D arrays of gold nanoparticles10.1021/acsphotonics.4c00591 ↗
94. PEGylated PLGA nanoparticles prepared from nano-emulsion templates as versatile platforms to cross blood-brain barrier models
95. Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer’s type10.1016/j.msec.2017.03.283 ↗
96. Treatment with isolated gold nanoparticles reverses brain damage caused by obesity
97. Systemic administration of gold nanoparticles attenuates anxiety-related behaviors and enhances spatial learning performance in rats10.1016/j.ibneur.2025.08.004 ↗
98. Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer’s type10.1016/j.msec.2017.03.283 ↗
99. Gold nanoparticles treatment reverses brain damage in Alzheimer's disease model10.1007/s12035-019-01780-w ↗
100. Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB10.3109/03639045.2013.861478 ↗